D2 Receptor/DAT Interaction Inhibitor (Centre for Addiction and Mental Health)

N/A

Report date: 2025/01/26 18:34:03

Base Information

Drug NameD2 Receptor/DAT Interaction Inhibitor (Centre for Addiction and Mental Health)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionDopamine transporter antagonistsDopamine D2 receptor agonists
TargetsDopamine transporterDopamine D2 receptor
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentre For Addiction And Mental Health
China Registration ClassN/A

Develop Information

Active CompaniesCentre For Addiction And Mental Health
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A